In addition, it disrupts oxidative phosphorylation–mediated cuproptosis and metabolic reprogramming through mitochondrial proteolipid acylation, thereby impairing insulin and energy metabolism (58, 82, 83) and accelerating the progression of DM and its complications (57, 84). Here, INS is linked to diabetes mellitus.